A Simplified Baculovirus-AAV Expression Vector System Coupled With One-step Affinity Purification Yields High-titer rAAV Stocks From Insect Cells

被引:191
作者
Smith, Richard H. [1 ]
Levy, Justin R. [1 ]
Kotin, Robert M. [1 ]
机构
[1] NHLBI, Lab Biochem Genet, Bethesda, MD 20892 USA
基金
美国国家卫生研究院;
关键词
RECOMBINANT ADENOASSOCIATED VIRUS; CHROMATOGRAPHIC PURIFICATION; TYPE-2; TRANSLATION; INITIATION;
D O I
10.1038/mt.2009.128
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Scalable methods of recombinant adeno-associated virus (rAAV) production have gained much recent interest as the field of rAAV-mediated gene therapy approaches the clinic. In particular, the production of rAAV vectors in insect cells via the use of recombinant baculovirus technology has proven to be an efficient and scalable means of rAAV production. Here, we describe a method for the production of rAAV serotypes 1 and 2 in insect cells using a simplified baculovirus-AAV expression-vector system coupled with particle purification via affinity chromatography. The number of separate baculovirus constructs required for rAAV production was reduced by genetically modifying the AAV rep gene to allow expression of the AAV-encoded replication enzymes, Rep78 and Rep52, from a single mRNA species and combining the modified rep gene with an AAV cap gene expression cassette in a single baculovirus construct. Additionally, we describe lysis, binding, and elution conditions compatible with a commercially available affinity medium (AVB Sepharose High Performance) used to purify rAAV particles to near homogeneity in a single chromatography step. Using the described method, we obtained an average yield of 7 x 10(4) purified rAAV particles per cell (range: 3.7 x 10(4) to 9.6 x 10(4)) from suspension cultures of recombinant baculovirus-infected insect cells.
引用
收藏
页码:1888 / 1896
页数:9
相关论文
共 31 条
[1]   Isolation of highly infectious and pure adeno-associated virus type 2 vectors with a single-step gravity-flow column [J].
Auricchio, A ;
Hildinger, M ;
O'Connor, E ;
Gao, GP ;
Wilson, JM .
HUMAN GENE THERAPY, 2001, 12 (01) :71-76
[2]   A versatile and scalable two-step ion-exchange chromatography process for the purification of recombinant adeno-associated virus serotypes-2 and-5 [J].
Brument, N ;
Morenweiser, R ;
Blouin, V ;
Toublanc, E ;
Raimbaud, I ;
Chérel, Y ;
Folliot, S ;
Gaden, F ;
Boulanger, P ;
Kroner-Lux, G ;
Moullier, P ;
Rolling, F ;
Salvetti, A .
MOLECULAR THERAPY, 2002, 6 (05) :678-686
[3]   Toward exascale production of recombinant adeno-associated virus for gene transfer applications [J].
Cecchini, S. ;
Negrete, A. ;
Kotin, R. M. .
GENE THERAPY, 2008, 15 (11) :823-830
[4]   Primary recovery and chromatographic purification of adeno-associated virus type 2 produced by baculovirus/insect cell system [J].
Chahal, Parminder S. ;
Aucoin, Marc G. ;
Kamen, Amine .
JOURNAL OF VIROLOGICAL METHODS, 2007, 139 (01) :61-70
[5]   Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors [J].
Chao, HJ ;
Liu, YB ;
Rabinowitz, J ;
Li, CW ;
Samulski, RJ ;
Walsh, CE .
MOLECULAR THERAPY, 2000, 2 (06) :619-623
[6]   Intron splicing-mediated expression of AAV rep and cap genes and production of AAV vectors in insect cells [J].
Chen, Haifeng .
MOLECULAR THERAPY, 2008, 16 (05) :924-930
[7]   Cloning and characterization of adeno-associated virus type 5 [J].
Chiorini, JA ;
Kim, F ;
Yang, L ;
Kotin, RM .
JOURNAL OF VIROLOGY, 1999, 73 (02) :1309-1319
[8]   Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses [J].
Clark, KR ;
Liu, XL ;
McGrath, JP ;
Johnson, PR .
HUMAN GENE THERAPY, 1999, 10 (06) :1031-1039
[9]   Purification of recombinant adeno-associated virus vectors by column chromatography and its performance in vivo [J].
Gao, GP ;
Qu, G ;
Burnham, MS ;
Huang, J ;
Chirmule, N ;
Joshi, B ;
Yu, QC ;
Marsh, JA ;
Conceicao, CM ;
Wilson, JM .
HUMAN GENE THERAPY, 2000, 11 (15) :2079-2091
[10]  
GAUDET D, 2008, MOL THER, V16, pS1